from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1670/-

LFCtreatmentdescriptionclass of inhibitor

1.547

Amikacinug/mL Amikacintranslation

1.801

Cap5-10ug/mL Capreomycintranslation

2.933

Rox10-50 ug/mL Roxithromycintranslation

1.648

SM2-5 ug/mL Streptomycintranslation

2.649

Tet5-10 ug/mL Tetracyclinetranslation

-0.080

Rif0.2-5ug/mL Rifampicintranscription

-1.273

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.490

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.360

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.724

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.130

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.342

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.535

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.507

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.083

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.007

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.426

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.359

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.207

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.061

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.504

Nigericin50 uM Nigericinrespiration

0.904

TRC10-150 ug/mL Triclosanrespiration

1.921

TRZ10-25 ug/mL Thioridazinerespiration

-0.213

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.221

menadione6-10 ug/mL Menadionerespiration

-0.233

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.553

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.541

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.665

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.518

NRP_1Non-replicating persistence stage 1dosRassociated

-0.390

Amp0.2mg/mL AmpicillincellWall

-0.491

Cephalexin20-100 ug/mL CephalexincellWall

0.136

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.557

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.281

EMB10-20 ug/mL EthambutolcellWall

-0.129

Eta12-40 ug/mL EthionamidecellWall

-0.313

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.376

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.227

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.257

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.269

BZA0.12 mg/mL BenzamidearomaticAmides

-0.562

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.080

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.123

H2O24 mM hydrogen peroxideDNAdamaging

-0.315

Levo10 ug/mL LevofloxacinDNAdamaging

-0.166

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.408

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.073

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.378

UVUV-irradiationDNAdamaging

0.405

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.443

Antimycin12.5-50 ug/mL Antimycin A?

-0.605

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.822

PA_110-50 ug/mL Antitubercular compound PA-1?

0.233

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.161

PA8240.2-2 ug/mL PA-824?

-0.401

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.503

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.292

Verapamil50 uM Verapamil?

-0.694

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.121

methoxatin10-20 ug/mL Methoxatin?